Weil, Gotshal & Manges LLP

Private Equity; Mergers & Acquisitions

Charles Ching is a partner in the Corporate Department and heads the Firm’s Asia practice. He represents financial sponsors and corporate clients on cross-border M&A and investment transactions, with particular focus on private equity investments in Asia, outbound M&A by Asian investors, and regional joint ventures and other corporate transactions. He regularly advises clients on some of the most complex and noteworthy public and private M&A transactions in the United States and globally, having practiced in New York and Hong Kong.

Charles Ching regularly represents sponsors and corporate clients in mergers and acquisitions, minority investments, PIPEs and other investment transactions, particularly those with a China focus. His private equity clients include Advent International, FountainVest Partners, Primavera Capital, Warburg Pincus and other international and China-based private equity houses.

He has also acted on some of the most prominent cross-border M&A transactions involving China in recent years, including TCL Zhonghuan Renewable Energy’s multiple investments in Maxeon Solar, Shanghai Pharmaceuticals’ acquisition of Cardinal Health’s China distribution business, HNA’s acquisition of stake in Hilton Worldwide, HNA’s acquisition of Ingram Micro and others.

English, Mandarin

Admitted as an attorney in New York and a solicitor in Hong Kong.